AND — Andlauer Healthcare Cashflow Statement
0.000.00%
- CA$2.08bn
- CA$2.22bn
- CA$650.48m
- 88
- 28
- 69
- 65
Annual cashflow statement for Andlauer Healthcare, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 37.7 | 90 | 76.3 | 66.1 | 64.5 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 3.13 | -38.5 | 1.52 | 1.5 | 3.12 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11.6 | -6.25 | -3.08 | -26.9 | -9.03 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 51 | 84.1 | 137 | 104 | 124 |
Capital Expenditures | -5.44 | -9.67 | -28 | -25.6 | -20.4 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -14.9 | -174 | -17.6 | 1.74 | 1.52 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -20.4 | -183 | -45.6 | -23.8 | -18.9 |
Financing Cash Flow Items | 13.4 | -6.2 | -0.67 | -0.188 | -1.8 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -19.2 | 93.9 | -51.6 | -86.2 | -126 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 11.4 | -5.16 | 40.9 | -6.12 | -19.3 |